Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alcon AG (ALC) vs Five Below Inc (FIVE) Price & Performance

Alcon AG
Five Below Inc

Price performance

Price movement over the last 24 hours

Key statistics

Alcon AG vs Five Below Inc — how do they compare? Alcon AG trades at $66.65 (market cap $32.69B), while Five Below Inc trades at $179.06 (market cap $9.75B). The key difference: Alcon AG is far larger — about 3.4× Five Below Inc's market cap, and Alcon AG pays a 0.54% dividend while Five Below Inc pays none. Which is the better fit depends on your goals.

ALCFIVE
Market Cap
$32.69B$9.75B
Sector
HealthConsumer Staples
52-Week High
$92.22$247.71
52-Week Low
$62.02$128.78
Enterprise Value
$36.28B$10.63B
Dividend Yield
0.54%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alcon AG

ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.

The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.

Five Below Inc

Five Below (FIVE) trades at $176.25, down 3.39% with a bearish technical signal despite strong earnings beats. The company shows solid revenue growth from $3.88B in 2025 to projected $5.1B in 2026, with net income margin improving to 8.67%. Recent news highlights digital marketing success and leadership appointments driving customer engagement. Technical indicators show oversold conditions with RSI at 24.82, while support levels begin at $174.

Analyst consensus remains strongly bullish with 58% buy ratings and $253 price target, representing 44% upside. Key risks include execution of expansion plans and consumer spending sensitivity. The combination of strong fundamentals, positive analyst sentiment, and current technical oversold conditions presents a compelling opportunity for growth investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Alcon AG

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Read more on ALC

About Five Below Inc

Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics

Read more on FIVE